Immunohistochemical expression of PTEN antigen: A new tool for diagnosis of early endometrial neoplasia;L'expression immunohistochimique de l'antigène PTEN: Un nouvel outil diagnostique dans les néoplasies débutantes de l'endomètre

Bulletin de l'Academie Nationale de Medecine

Volumn 188, Issue 3, 2004, Pages 415-429

  Taranger Charpin, Colette ^a   Carpentier, Séverine ^a   Dales, Jean Philippe ^a   Garcia, Stéphane ^a   Djemli, Amina ^a   Andrac, Lucile ^a   Lavaut, Marie Noëlle ^a   Sferlazzo, Karine ^b   Boubli, Léon ^a   Nezeloff, Christian ^c   Bourel, Michel ^c   Laccourreye, Henri ^c   Sraer, Jean Daniel ^c   Crépin, Gilles ^c   Binet, Jacques Louis ^c  

^a HÔPITAL NORD   (France)

^b Chemin des Bourrelly   (France)

^c NONE

Author keywords

Endometrial hyperplasia; Immunocytochemistry; Menopause

Indexed keywords

PARAFFIN; PTEN PROTEIN;

ADENOSQUAMOUS CARCINOMA; ANTIGEN EXPRESSION; CANCER DIAGNOSIS; CARCINOMA IN SITU; CELL PROLIFERATION; CLEAR CELL CARCINOMA; EARLY DIAGNOSIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MENOPAUSE; PAPILLARY CARCINOMA; PROTEIN EXPRESSION; REVIEW; SAMPLE;

EID: 7044274135     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33772-0     Document Type: Review

References (13)

1. BOCKMAN J.V. - Two pathogenetic types of endometrial carcinoma. Gynecology Oncology, 1983, 15, 10-17.
2. MUTTER G.L., LIN M.-C., FITZGERALD J.T., KUM J.B., BAAK J.P.A., LEES J.A., WENG L.-P., ENG C. - Altered PTEN expression as a diagnosis marker for the earliest endometrials precancers. J. Natl. Canc. Inst., 2000, 92, 924-931.
3. MATIAS-GUIU X., CATASUS/., BUSSAGLIA E., LAGARDA H., GARCIA A., PON MUNOZ J., ARGUELLES R., MACHIN P., PRAT J. - Molecular pathology of endometrial hyperplasia and carcinoma. Hum. Pathol., 2001, 32, 569-577.
4. KOUL A., WILLE N.R., BENDAHL P.O., NILBERT M., BORG A. - Distinct sets of gene alterations in endometrial carcinoma in alternate odes of tumorigenesis. Cancer, 2002, 94, 2369-79.
5. MUTTER G.L., INCE T.A., BAAK J.P.A., KUST G.A., ZHU X.-P., ENG C. - Molecular identification of latent precancers in histologically normal endometrium. Cancer res., 2001, 61, 4311-4314.
6. SALVENSEN H.B., MAC DONALD N., RYAN A., JACOBS I.J., LYNCH E.D., AKSLEN L.A., DAS S. - PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J. Canc., 2001, 1, 22-26.
7. FUJITA N., TSURUO T. - Survival-signaling pathway as a promising target for cancer chemotherapy. Cancer Chemother Pharmacol, 2003, 52, 24-28.
8. MUTTER G.L. - Histopathology of genetically defined endometrial precancers. Int. J. Gynecol. Path., 2000, 19, 301-309.
9. BERGERON C., NOGALES F.F., MASSEROLI M., ABELER V., DUVILLARD P., MULLER-HOLZNER E., PICKARTZ H., WELLS M. - A multicentric european study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am. J. Surg. Path., 1999, 23, 1102-1108.
10. SALVENSEN H.B., STEFANSSON I., KALENES M.B., DAS S., AKSLEN L.A. - Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. Cancer, 2002, 94, 2185-2191.
11. KURMAN R., KAMINSKI P., NORRIS H. - The behavior of endometrial hyperplasia: a long terme study of "untreated" hyperplasia in 170 patients. Cancer, 1985, 56, 403-412.
12. SHERMAN A., BROWN S. - The Precursors of endometrial carcinoma. Am. J. Obst. Gynecol., 1979, 135, 943-954.
13. SCULLY R.E., BONIFAGLIO T.A., KURMAN R.J., SILVERBERG S.G., WILKINSON E.J. - International histological classification and typing of female genital tract tumours. 1994, New York - Springer-Verlag.